DGAP-News: MeVis Medical Solutions AG: MeVis' profitability remains high with stable revenues
(firmenpresse) - DGAP-News: MeVis Medical Solutions AG / Key word(s): Half Year
Results/Interim Report
MeVis Medical Solutions AG: MeVis' profitability remains high with
stable revenues
26.08.2013 / 07:30
---------------------------------------------------------------------
Sales increase of 9 % in the second quarter offsets decline in sales from
the previous quarter
- Consolidated sales after the first six month with EUR 6.9 million
stabilized on the level of the previuos year
- Maintenance business contributes 44 % to the revenues (prev. year: 43
%)
- Earnings before interest and taxes (EBIT) again significantly increased
by 30 % to EUR 1.6 million (prev. year: EUR 1.3 million)
- Consolidated net profit also increased considerably to EUR 1.6 million
(prev. year: EUR 0.7 million)
- Liquidity raised to EUR 9.6 million (December 31, 2012: EUR 8.7
million)
Bremen, August 26, 2013 - Today, MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a leading software provider for the medical imaging market,
announced its results for the first half of 2013.
Sales in the second quarter of 2013 exceeded the prior-year quarter with
EUR 3,544 k, by 9 % (EUR 3,241 k). At EUR 6,862 k, sales in the first half
of the year were constant year on year (prev. year: EUR 6,878 k).
Maintenance and service revenues again rose by 2 % to EUR 3,036 k (prev.
year: EUR 2,978 k) and contributed 44 % of total revenue (prev. year: 43
%). In contrast, license sales declined slightly by 4 % to EUR 3,520 k
(prev. year: EUR 3,670 k)
Sales in the Digital Mammography segment went up slightly by 1 % to EUR
5,186 k (prev. year: EUR 5,145 k). In contrast, sales in the Other
Diagnostics segment declined by 3 % to EUR 1,676 k (prev. year: EUR 1,733
k).
Capitalized development expenses were significantly reduced by 46 % in the
first half of 2013 year on year to EUR 760 k (prev. year: EUR 1,409 k).
Operating costs were again significantly reduced in the second quarter of
2013. Personnel expenses amounted to EUR 1,927 k, 9 % down on the
prior-year quarter. For the first half of the year, this corresponds to a
total drop of 12 %. Other operating expenses also decreased to EUR 434 k,
corresponding to a 21 % drop year on year.
After depreciation and amortization of EUR 1,033 k (38 % down year on year)
the first half of 2013 results in an EBIT (earnings before interest and
taxes) of EUR 1,638 k up a significant 30 % on the prior-year figure of EUR
1,256 k, mainly due to a consistent cost management. The EBIT margin
increased to 24 % (prev. year: 18 %).
With a net financial result of EUR -82 k and very low income tax the first
half of 2013 closed on a very positive note, with consolidated net profit
of EUR 1,551 k (prev. year: EUR 666 k). This resulted in earnings per share
of EUR 0.90 (prev. year: EUR 0.39).
Cash and cash equivalents went up in the first half of 2013 by EUR 902 k to
EUR 9,568 k (EUR 8,665 k as of December 31, 2012).
'Based on our current performance we are raising our forecast for 2013. We
now expect a stable growth in sales instead of a slight decline in sales.
In our assessment the Group's earnings before interest and taxes (EBIT) are
substantially influenced by the sales performance, by a reduced
capitalization of development costs and by a further slight reduction in
personnel expenses and other operating expenses. Overall for 2013, we now
expect anincrease in EBIT instead of a slight decline. Further, we expect
a positive cash flow for this year.' said Dr. Robert Hannemann, CFO of
MeVis Medical Solutions AG. 'We are also pleased that we have largely
completed the streamlining of the Group structure with the merger of MeVis
BreastCare Solutions (MBS) with its parent company MMS AG, which came into
effect on August 1.'
'Now that the consolidation measures have largely been concluded with
corresponding positive effects on our results we have laid a solid
foundation for MeVis' future growth.' added Marcus Kirchhoff, CEO of MeVis
Medical Solutions AG. 'We will continue to focus on the development and
implementation of measures to generate future sales growth. We have also
continued our promising talks with potential new industrial customers to
gain additional customers in our core business of selling software licenses
and therefore to modify and expand our product portfolio to meet the needs
of our customers. In order to build up the business with internet-based
services, we will launch initial services on the market in the fourth
quarter of this year and gradually expand these services.'
The financial reports of the company can be downloaded here:
http://www.mevis.de/ir_finanzberichte.html
End of Corporate News
---------------------------------------------------------------------
26.08.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir(at)mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
227387 26.08.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.08.2013 - 07:30 Uhr
Sprache: Deutsch
News-ID 290695
Anzahl Zeichen: 5199
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 303 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MeVis Medical Solutions AG: MeVis' profitability remains high with stable revenues"
steht unter der journalistisch-redaktionellen Verantwortung von
MeVis Medical Solutions AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
